Anna Di Blasio
Impact in
- Reproductive Medicine top 10%
- Ovarian function and disorders
- Ovarian cancer diagnosis and treatment
-
- Blood properties and coagulation
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Chemokine receptors and signaling 2
-
- Lung Cancer Treatments and Mutations 2
- Renal cell carcinoma treatment 1
- Co-authors
- Roberto Marchioli (1 shared paper)Giulio Maresca (1 shared paper)Giovanni Di Minno (1 shared paper)Silvio Rea (11 shared papers)F. Recchia (11 shared papers)Gaetano Saggio (10 shared papers)Giampiero Candeloro (9 shared papers)Alisia Cesta (9 shared papers)
In The Last Decade
Anna Di Blasio
17 papers receiving 479 citations
Peers
Comparison fields: 5 of 70
- Reproductive Medicine 52
- Pulmonary and Respiratory Medicine 125
- Endocrinology, Diabetes and Metabolism 50
- Internal Medicine 10
- Public Health, Environmental and Occupational Health 77
Countries citing papers authored by Anna Di Blasio
This map shows the geographic impact of Anna Di Blasio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Di Blasio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Di Blasio more than expected).
Fields of papers citing papers by Anna Di Blasio
This network shows the impact of papers produced by Anna Di Blasio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Di Blasio. The network helps show where Anna Di Blasio may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Di Blasio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 253 | |
| 2 | 2005 | 97 | |
| 3 | 2006 | 23 | |
| 4 | 2005 | 23 | |
| 5 | 2007 | 19 | |
| 6 | 2016 | 16 | |
| 7 | 1997 | 14 | |
| 8 | 2007 | 10 | |
| 9 | 2001 | 9 | |
| 10 | 2016 | 7 | |
| 11 | Multicenter phase II study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer. | 2003 | 7 |
| 12 | 2007 | 6 | |
| 13 | 2003 | 6 | |
| 14 | 2002 | 6 | |
| 15 | Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. | 2006 | 3 |
| 16 | 2013 | 1 | |
| 17 | 2006 | 1 |
About Anna Di Blasio
Anna Di Blasio is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology, having authored 17 papers that have together received 501 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Renin-Angiotensin System Studies (2 papers), Chemokine receptors and signaling (2 papers), Lung Cancer Treatments and Mutations (2 papers), Renal cell carcinoma treatment (1 paper), Moyamoya disease diagnosis and treatment (1 paper), Genetic Neurodegenerative Diseases (1 paper) and Migraine and Headache Studies (1 paper). The work is most often cited by research in Reproductive Medicine (52 citations), Pulmonary and Respiratory Medicine (125 citations), Endocrinology, Diabetes and Metabolism (50 citations), Internal Medicine (10 citations) and Public Health, Environmental and Occupational Health (77 citations). Anna Di Blasio has collaborated with scholars based in Italy and Guatemala. Frequent co-authors include Roberto Marchioli, Giulio Maresca, Giovanni Di Minno, Silvio Rea, F. Recchia, Gaetano Saggio, Giampiero Candeloro, Alisia Cesta, Stefano Necozione and Antonio Nuzzo. Their work appears in journals such as Journal of Immunotherapy, Journal of Hypertension, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Clinical Oncology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.